honokiol has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Dai, YQ; Li, BH; Li, HM; Ma, H; Wu, CZ; Zhang, XJ; Zhu, J | 1 |
| Katiyar, SK; Singh, T | 1 |
2 other study(ies) available for honokiol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Semisynthesis and anti-cancer properties of novel honokiol derivatives in human nasopharyngeal carcinoma CNE-2Z cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Testicular Neoplasms | 2023 |
Honokiol, a phytochemical from Magnolia spp., inhibits breast cancer cell migration by targeting nitric oxide and cyclooxygenase-2.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biphenyl Compounds; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Movement; Cyclooxygenase 2; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Female; Humans; Lignans; Magnolia; Mice; Models, Biological; Molecular Targeted Therapy; Nitric Oxide; Phytotherapy | 2011 |